Journal of Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

A Systematic Review of Tuberculosis Diagnosis Using a Breath Test


Karan Madan*

Despite concerted efforts over the last two decades to develop new diagnostics, drugs and vaccines, tuberculosis remains a global emergency. Several novel diagnostic technologies, such as nucleic acid-based amplification tests, imaging and volatile organic compound breath analysis, show promise for improved point-of-care rapid tests for tuberculosis. Advances in new and repurposed drugs for use in multidrug-resistant (MDR) or extensively drug-resistant (XDR) tuberculosis have focused on the development of several new drug regimens and their clinical trial evaluation and they now influence World Health Organization guidelines. Since the failure of the MVA85A vaccine two years ago, no new tuberculosis vaccine candidates have entered clinical trials.


Share this article

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 1605

Journal of Molecular Biomarkers & Diagnosis received 1605 citations as per Google Scholar report

Journal of Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

arrow_upward arrow_upward